Jilin Aodong Pharmaceutical

Jilin Aodong Pharmaceutical is one of the...

• CSI 500.

Jilin Aodong Pharmaceutical is a company listed under the stock ticker 000623 (CN).

View the org chart displaying its 10 main executives

Most searched biographies at Jilin Aodong Pharmaceutical

• Shuqin Guo, Vice Chairman of the Board, General Manager
• Weiwei Xiao, Independent Director
• Liang Biming, Director

Create your alert
to follow the executive moves at Jilin Aodong Pharmaceutical.

Jilin Aodong Pharmaceutical has 1,869 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Jilin Aodong Pharmaceutical

Social media about Jilin Aodong Pharmaceutical

• Jilin Aodong Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Jilin Aodong Pharmaceutical on LinkedIn, Twitter & YouTube

Contact by email its executives including Shuqin Guo

Call Jilin Aodong Pharmaceutical at +86 433...

View the org chart

Register to receive your alert

Report an error